UCB v. Alembic (Lacosamide)

Carlson Caspers represents Alembic in a case concerning Alembic’s efforts to market a generic version of UCB’s Vimpat® (lacosamide) product by challenging infringement and validity of the asserted patent.  The case is currently pending.